Hot Start dNTPs - A Novel Tool for Controlled Nucleotide Incorporation in PCR
Poster Jan 08, 2010
Tony Le, Elena Hidalgo Ashrafi, Sabrina Shore, Victor Timoshchuk, Natasha Paul, Richard Hogrefe, Inna Koukhareva, Alexandre Lebedev
PCR is a widely used scientific tool employed by a variety of applications. Various Hot Start technologies have already been developed using modified PCR components to increase specificity of a reaction. Recently developed CleanAmpTM dNTPs are modified nucleoside triphosphates with a thermolabile 3’-tetrahydrofuranyl protecting group that is released at higher temperatures. These modified dNTPs prevent low temperature primer extension, which can often be a significant problem in PCR. At higher temperatures, the modified dNTPs are deprotected, to allow for incorporation by the DNA polymerase and more specific amplification of the intended target. The use of CleanAmpTM dNTPs provides comparable performance to other Hot Start technologies and shows promise to provide a synergistic effect when used in conjunction with other Hot Start methods. This modified dNTP technology also has the ability to use any DNA polymerase in a Hot Startsystem, which can be very cost effective. Although the utility of CleanAmpTM dNTPs in traditional Hot Start PCR has been previously demonstrated, they can also be used in more advanced PCR applications that require temperature-controlled nucleotide incorporation. In these advanced applications, the CleanAmp TM dNTP modification blocks nucleotide incorporation during initial, lower temperature reactions, allowing for delayed nucleotide activation in a reaction. In summary, CleanAmpTM dNTPs have the potential to provide great versatility and flexibility in a vast number of applications including traditional Hot Start PCR.
Despite the developments in conventional PCR, the complexity of multiplex Real Time PCR is still limited due to the lack of sufficient detection channels. To achieve high-end multiplexing capacity on standard Real Time PCR machines, Anapa Biotech has developed the MeltPlex® technology (see box on right).READ MORE
Genome-wide association studies (GWAS) have identified more than 100 genetic loci associated with type 2 diabetes. The majority of these are located in the intergenic or intragenic regions suggesting that the implicated variants may alter chromatin conformation. This, in turn, is likely to influence the expression of nearby or more remotely located genes to alter beta cell function. At present, however, detailed molecular and functional analyses are still lacking for most of these variants. We recently analysed one of these loci and mapped five causal variants in an islet-specific enhancer cluster within the STARD10 gene locus. Here, we aimed to understand how these causal variants influence b-cell function by alteration of the chromatin structure of enhancer clusterREAD MORE
2nd International Conference on Pharmaceutical Research & Innovations in Pharma Industry
May 30 - May 31, 2019